ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
ORKA
26 hedge funds and large institutions have $5.02M invested in Oruka Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
3
Closed
1
Calls
$148K
Puts
$213K
Net Calls
-$65K
Net Calls Change
-$99K
Top Buyers
| 1 |
1
Group One Trading
Chicago,
Illinois
|
$45.8K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$50.2K |
| 3 |
3
Charles Schwab
San Francisco,
California
|
$29.8K |
| 4 |
HF
4
HRT Financial
New York
|
$28K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$930K |
Top Sellers
| 1 |
BCM
1
BML Capital Management
Zionsville,
Indiana
|
$1.41M |
| 2 |
NM
2
Newtyn Management
New York
|
$1.03M |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$62 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$34.6K | -1,215 | Closed |
|